3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
TP53 Y220C Mutation
1
Smoking
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Peripheral Nervous System Diseases
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Mantle-Cell
1
Localized Prostate Cancer
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Genetic Diseases, Inborn
1
Deglutition Disorders
1
Cognitive Dysfunction
1
Interventions
pembrolizumab
23
Paclitaxel
23
Carboplatin
15
Specimen Handling
13
Bevacizumab
12
Magnetic Resonance Spectroscopy
10
Doxorubicin
8
Biopsy
8
lenvatinib
7
Taxes
7
olaparib
6
Letrozole
6
Fulvestrant
6
Cisplatin
6
dostarlimab
5
Nivolumab
5
Gemcitabine
5
abemaciclib
4
X-Rays
4
Trastuzumab
4
Oxaliplatin
4
Medroxyprogesterone Acetate
4
Immunoglobulin G
4
Fluorouracil
4
Docetaxel
4
trastuzumab deruxtecan
3
palbociclib
3
ipatasertib
3
durvalumab
3
Tirzepatide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Tablets
×
90 days
×
Clear all
No trials found.